Global Markets: Stocks hold near record as investors weigh vaccine hope and virus concern
By Chuck Mikolajczak NEW YORK (Reuters) - A gauge of global stocks held near a record on Tuesday, even as rising coronavirus cases raised concerns about fresh lockdown measures and tamped down recent optimism over promising vaccine trial results. U.S
By Chuck Mikolajczak
NEW YORK (Reuters) - A gauge of global stocks held near a record on Tuesday, even as rising coronavirus cases raised concerns about fresh lockdown measures and tamped down recent optimism over promising vaccine trial results.
U.S. stocks had moved off their worst levels of the day but the Dow and S&P 500 remained in the red as several states imposed new restrictions on gatherings amid climbing COVID-19 cases and the onset of colder weather.
The Nasdaq was able to show a modest gain, however, in part due to a 9.25% jump in Tesla
Investors cheered positive vaccine trial results from Moderna
"You have that push and pull of you had the Pfizer news last week and the Moderna news this week," said Tom Hainlin, global investment strategist at U.S. Bank Wealth Management's Ascent Private Wealth Group in Minneapolis.
"We haven’t had a lot of follow through because the pull on the other side is watching the case growth and watching the states enact renewed restrictions on an individual’s mobility and business activity."
Still, analysts have warned that absent a new fiscal stimulus package, the economy is likely to falter until a vaccine is available for distribution.
Data on Tuesday showed retail sales increased less than forecast in October, with the potential for even further slowing. Factory production accelerated but remained well below levels prior to the pandemic.
Federal reserve Chair Jerome Powell said on Tuesday that the current surge in coronavirus cases is a big concern, and the economy will continue to need both fiscal and monetary policy support.
The Dow Jones Industrial Average <.DJI> fell 145.93 points, or 0.49%, to 29,804.51, the S&P 500 <.SPX> lost 8.7 points, or 0.24%, to 3,618.21 and the Nasdaq Composite <.IXIC> added 11.40 points, or 0.1%, to 11,935.52.
European shares closed lower, as the STOXX 600 dipped from an eight-month high, as Sweden moved to restrict the size of public gatherings and a British medical adviser suggested strengthening the three-tier system of restrictions when the full lockdown in England ends.
The pan-European STOXX 600 index <.STOXX> lost 0.24% and MSCI's gauge of stocks across the globe <.MIWD00000PUS> gained 0.01% after closing at a record 613.61 in the prior session.
U.S. Treasury yields fell in the wake of the retail sales report as it underscored the possibility of a slowdown in the fourth quarter.
Benchmark 10-year notes
The U.S. dollar remained soft, touching its lowest level in a week, with expectations for continued weakness on expectations for more fiscal and monetary stimulus as well as optimism over a potential vaccine.
The dollar index <=USD> fell 0.077%, with the euro
The offshore Chinese yuan rose to its highest since June 2018 against the dollar, as positive economic data in the world's second largest economy buoys the currency.
(GRAPHIC: China's Yuan is surging - https://fingfx.thomsonreuters.com/gfx/mkt/xegpbqjmlvq/Pasted%20image%201605617145961.png)
Crude prices fell back, as short-term demand concerns overshadowed vaccine hopes and the possibility of tighter supply policy from OPEC+ in 2021.
(Reporting by Chuck Mikolajczak; additional reporting by Shriya Ramakrishnan in Bengaluru; Editing by Steve Orlofsky and Tom Brown)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Howard Schneider WASHINGTON (Reuters) - The explosive surge in U.S. coronavirus cases this fall has left a question hanging: When will the economy take its own turn for the worse
FRANKFURT/WASHINGTON (Reuters) - The heads of the Federal Reserve and the European Central Bank welcomed the encouraging results in trials of a vaccine candidate for the novel coronavirus but stressed that the economic outlook will remain uncertain. Fed chair Jay Powell and ECB President Christine Lagarde said the economy was still in for a tough time even if the development of a potential vaccine by U.S. drugmaker Pfizer and German partner BioNTech SE was reason for some optimism further ahead
By Sumita Layek (Reuters) - India's fuel consumption in October registered its first year-on-year increase since February, as slowing coronavirus cases and increased mobility accelerated an economic recovery, data showed on Thursday.